The Medical Technology Association of Australia (MTAA) today welcomed the findings of the Senate Inquiry into the price regulation associated with the Prostheses List Framework. The Senate Committee report clearly reflected the complexity of the issues involved in medical device pricing and rejected the slash and burn approach advocated by the private health insurers. The recommendations of the report are sensible and MTAA supports them.
Medical device makers recognise the need for reform of the Prostheses List but it needs to be based on the best data, according to CEO of the Medical Technology Association of Australia (MTAA), Ian Burgess.
Mr Burgess spoke with HealthDispatch in a week during which the MTAA released its own data on prostheses pricing and continues to argue with private health insurers over the extent and nature of reform.